These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1791229)

  • 1. Extracorporeal photochemotherapy: a potentially useful treatment for scleromyxedema.
    Berkson M; Lazarus GS; Uberti-Benz M; Rook AH
    J Am Acad Dermatol; 1991 Oct; 25(4):724. PubMed ID: 1791229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus].
    D'Incan M; Franck F; Kanold J; Bacin F; Achin R; Beyvin AJ; Demeocq F; Souteyrand P
    Ann Dermatol Venereol; 2001 Jan; 128(1):38-41. PubMed ID: 11226899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide as a potential treatment for scleromyxedema.
    Caradonna S; Jacobe H
    Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
    Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
    J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scleromyxedema: immunosuppressive therapy with cyclophosphamide].
    Aberer W; Wolff K
    Hautarzt; 1988 May; 39(5):277-80. PubMed ID: 3403262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
    Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of intractable scleromyxedema with cyclosporin A.
    Saigoh S; Tashiro A; Fujita S; Matsui M; Shibata S; Takeshita H; Duan H; Moroi Y; Urabe K; Koga T; Furue M
    Dermatology; 2003; 207(4):410-1. PubMed ID: 14657639
    [No Abstract]   [Full Text] [Related]  

  • 8. [Initial scleromyxedema. Successful treatment with melphalan].
    Schubert K; Stein A; Meurer M
    Hautarzt; 2002 Jul; 53(7):478-82. PubMed ID: 12219271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scleromyxedema with laryngeal changes. Beneficial results of the treatment with mucopolysaccharidases].
    Cosgarea R; Cosgarea M; Turcu T
    Ann Dermatol Venereol; 1994; 121(2):159-61. PubMed ID: 7979029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of scleromyxedema associated with isotretinoin therapy.
    Hisler BM; Savoy LB; Hashimoto K
    J Am Acad Dermatol; 1991 May; 24(5 Pt 2):854-7. PubMed ID: 2050852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SCLEROMYXEDEMA - SCLERODERMA OR MYXEDEMA?].
    JANSEN LH; CLAESSENS FL; BERRENS L
    Hautarzt; 1964 May; 15():223-8. PubMed ID: 14213268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Scleromyxedema].
    JANSEN LH; REYERS JG; van BAAK
    Ned Tijdschr Geneeskd; 1961 Mar; 105():407-11. PubMed ID: 13789480
    [No Abstract]   [Full Text] [Related]  

  • 13. Extracorporeal photochemotherapy in nodular scleroderma.
    Wollina U; Looks A; Lange D
    Br J Dermatol; 1998 Sep; 139(3):559-60. PubMed ID: 9767323
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of autoimmune disease with extracorporeal photochemotherapy: progressive systemic sclerosis.
    Rook AH; Freundlich B; Nahass GT; Washko R; Macelis B; Skolnicki M; Bromley P; Witmer WK; Jegasothy BV
    Yale J Biol Med; 1989; 62(6):639-45. PubMed ID: 2636803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photochemotherapy for systemic and localized scleroderma.
    De Rie MA; Bos JD
    J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642
    [No Abstract]   [Full Text] [Related]  

  • 16. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis.
    Jablonska S; Blaszczyk M
    Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carnitine and diseases of the connective tissue].
    Strack E; Nitschner H; Liebsch F
    Dtsch Gesundheitsw; 1970 Jun; 25(26):1233-6. PubMed ID: 5515092
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arndt-Gottron scleromyxedema].
    Piper W; Hardmeier T
    Verh Dtsch Ges Inn Med; 1967; 73():394-9. PubMed ID: 5591783
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin.
    Karim A; Lawlor F; Black MM
    Clin Exp Dermatol; 2004 May; 29(3):317-8. PubMed ID: 15115524
    [No Abstract]   [Full Text] [Related]  

  • 20. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work.
    Lin YC; Wang HC; Shen JL
    J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.